Business Description
Turk Ilac ve Serum Sanayi
ISIN : TRETRLC00022
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.91 | |||||
Debt-to-EBITDA | 2.77 | |||||
Interest Coverage | 1.2 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.51 | |||||
Beneish M-Score | 0.35 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 112.5 | |||||
3-Year EBITDA Growth Rate | 47.8 | |||||
3-Year EPS without NRI Growth Rate | 48.3 | |||||
3-Year FCF Growth Rate | 131.9 | |||||
3-Year Book Growth Rate | 102.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 88.51 | |||||
9-Day RSI | 75.14 | |||||
14-Day RSI | 64.34 | |||||
6-1 Month Momentum % | -37.99 | |||||
12-1 Month Momentum % | 51.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.51 | |||||
Quick Ratio | 1.97 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 62.33 | |||||
Days Sales Outstanding | 261.63 | |||||
Days Payable | 57.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -33.46 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 38 | |||||
Operating Margin % | 26.82 | |||||
Net Margin % | 16.38 | |||||
FCF Margin % | -46.98 | |||||
ROE % | 18.84 | |||||
ROA % | 9.3 | |||||
ROIC % | 22.69 | |||||
ROC (Joel Greenblatt) % | 25.06 | |||||
ROCE % | 27.03 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 10.89 | |||||
PE Ratio without NRI | 10.97 | |||||
PEG Ratio | 0.25 | |||||
PS Ratio | 1.66 | |||||
PB Ratio | 1.58 | |||||
Price-to-Tangible-Book | 1.73 | |||||
EV-to-EBIT | 8.55 | |||||
EV-to-EBITDA | 7.97 | |||||
EV-to-Revenue | 2.94 | |||||
EV-to-FCF | -5.92 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.12 | |||||
Price-to-Graham-Number | 0.96 | |||||
Price-to-Net-Current-Asset-Value | 13.36 | |||||
Earnings Yield (Greenblatt) % | 11.7 | |||||
FCF Yield % | -26.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Turk Ilac ve Serum Sanayi Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₺) | 1,552.348 | ||
EPS (TTM) (₺) | 1.563 | ||
Beta | 0 | ||
Volatility % | 67.41 | ||
14-Day RSI | 64.34 | ||
14-Day ATR (₺) | 0.614962 | ||
20-Day SMA (₺) | 16.842 | ||
12-1 Month Momentum % | 51.18 | ||
52-Week Range (₺) | 11.19 - 39.18 | ||
Shares Outstanding (Mil) | 161.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Turk Ilac ve Serum Sanayi Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Turk Ilac ve Serum Sanayi Stock Events
Event | Date | Price(₺) | ||
---|---|---|---|---|
No Event Data |
Turk Ilac ve Serum Sanayi Frequently Asked Questions
What is Turk Ilac ve Serum Sanayi(IST:TRILC)'s stock price today?
When is next earnings date of Turk Ilac ve Serum Sanayi(IST:TRILC)?
Does Turk Ilac ve Serum Sanayi(IST:TRILC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |